March Journal Club

When:  Mar 17, 2026 from 02:00 PM to 03:00 PM (CT)

Listen to critical evaluations of hematology/oncology pharmacy publications presented by PGY2 Oncology Residents.

The March Journal Club webinar will feature:

  • "Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial" presented by Anna Wszeborowska, PharmD - Hospital of the University of Pennsylvania, Philadelphia, PA
  • "Ianalumab Plus Eltrombopag in Immune Thrombocytopenia" presented by Zachary Zawacki, PharmD - Munson Medical Center, Traverse City, MI

March's moderator is Jeremy Pappacena, PharmD, BCOP, UW Health, University of Madison, Madison, WI

Location

Online Instructions:
Url: https://www.pathlms.com/hopa/courses/125647
Login: Register and learn more about the session at the link above.
Register Now

Related Content